STOCK TITAN

Echostar Corp Form 4 Filings

SATS NASDAQ

Every Form 4 that Echostar Corp (SATS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SATS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SATS filings page.

Rhea-AI Summary

EchoStar CORP EVP and CFO Paul W. Orban reported routine equity compensation activity. He received 297 restricted stock units that vest at 10% per year beginning on July 1, 2026, with each unit delivering one share of Class A Common Stock upon vesting.

The filing also shows 9 shares of Class A Common Stock withheld to cover tax obligations related to vested restricted stock units, a non‑market transaction. Following these updates, Orban holds 50,943 Class A shares directly and 37 shares indirectly through a 401(k) plan.

Rhea-AI Summary

EchoStar director James DeFranco reported routine equity compensation activity in Class A Common Stock. He received a grant of 198 restricted stock units (RSUs), each representing one share to be issued upon vesting. The RSUs vest 25% per year beginning on July 1, 2026.

The filing also shows 16 shares withheld to cover tax obligations related to vesting of prior anniversary awards. Following these transactions, DeFranco directly holds 1,870 shares and has additional indirect holdings through retirement and partnership or LLC interests, some of which he disclaims beneficial ownership.

Rhea-AI Summary

EchoStar CORP director Dodge R. Stanton automatically exercised a Non-Employee Director Stock Option for 5,000 shares of Class A Common Stock at $24.4900 per share. The option was fully vested and exercised automatically upon expiration under the company’s 2017 Non-Employee Director Stock Option Plan.

To cover the option exercise price and related tax obligations, 1,214 shares of Class A Common Stock were withheld by EchoStar at $100.8800 per share, a non‑market, tax-withholding disposition. Following these transactions, Stanton directly held 25,341 shares of Class A Common Stock and indirectly held 1,642 shares through a 401(K) account.

Rhea-AI Summary

EchoStar director Lisa W. Hershman automatically exercised options for 10,000 shares of Class A Common Stock at an exercise price of $24.49 per share under the company’s 2017 Non-Employee Director Stock Option Plan. In connection with this automatic exercise, 2,428 shares were withheld by EchoStar to cover the option exercise price and related tax obligations, rather than being sold in the open market. Following these transactions, Hershman directly holds 7,572 shares of Class A Common Stock, and the exercised director stock option, which was fully vested at grant, has expired with no remaining derivative position reported.

Rhea-AI Summary

EchoStar Corp director and senior advisor Cantey Ergen reported routine equity compensation and related tax withholding. She received a grant of 198 restricted stock units (RSUs), each representing a contingent right to one share of Class A Common Stock that vests 25% per year beginning on July 1, 2026. In connection with previously granted anniversary shares, 17 shares were withheld to cover tax obligations rather than sold on the market.

After these updates, she directly holds 2,148 Class A shares, including the 198 newly awarded RSUs and 1,967 shares of common stock. The filing also lists substantial indirect holdings in various family accounts, an LLC, a charitable foundation, and a child’s account, where she generally disclaims beneficial ownership except for any pecuniary interest.

Rhea-AI Summary

Ergen Two-Year June 2025 SATS GRAT, a major holder of EchoStar, reported a bona fide gift of 2,316,533 shares of Class B Common Stock to Charles W. Ergen as an annuity payment. After this distribution, the GRAT holds 14,483,467 Class B shares and is scheduled to expire on June 26, 2027.

Rhea-AI Summary

EchoStar CORP insiders Charles W. Ergen and Cantey M. Ergen reported internal equity transfers involving Class B Common Stock of SATS on June 26, 2026. The Form 4 shows two bona fide gift transactions totaling 4,633,066 Class B shares, structured as derivative positions convertible into an equal number of Class A shares for no additional consideration.

According to the disclosures, the Ergen Two-Year June 2025 SATS GRAT distributed 2,316,533 Class B shares to Mr. Ergen as an annuity payment on June 26, 2026, and held 14,483,467 Class B shares afterward. Other SATS GRATs established in 2024 and 2025 together hold tens of millions of Class B shares, while additional direct and indirect positions in Class A Common Stock remain. The filing records no open‑market purchases or sales; activity consists of gifts and trust-related movements.

Rhea-AI Summary

EchoStar CORP insiders Charles and Cantey Ergen reported estate-planning related share movements rather than market trades. The Form 4 shows bona fide gifts totaling 8,600,000 Class B Common Stock on June 15, 2026, split into two transactions of 4,300,000 shares each.

One 4,300,000-share gift moved Class B stock as an indirect holding, and another 4,300,000-share gift reduced the direct Class B position to 71,914 shares afterward. Footnotes explain that on June 15, 2026 Mr. Ergen created the Ergen Two-Year June 2026 SATS GRAT and contributed 4,300,000 Class B shares to this grantor retained annuity trust.

After these changes, the filing lists 11,140,269 Class A shares held directly and multiple large indirect Class B positions held through GRATs and entities such as Telluray Holdings, LLC and nXgen Opportunities, LLC. The Class B shares may be converted into an equal number of Class A shares at any time for no additional consideration.

Rhea-AI Summary

EchoStar CORP chief legal officer Dean Manson reported option exercises and related share sales in Class A Common Stock. On June 12, 2026, he exercised 10,000 employee stock options at an exercise price of $14.04 per share and sold 10,000 shares in open-market transactions at $130.39 per share. These trades were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2026, indicating they were pre-arranged. Following the transactions, he directly held 5,058 shares and indirectly held 1,143 shares of EchoStar Class A Common Stock, with no remaining derivative positions shown in this filing.

Rhea-AI Summary

EchoStar CORP director and officer Hamid Akhavan reported a mix of option exercises and share sales in Class A Common Stock. On June 5, 2026, he exercised a total of 142,917 employee stock options at $14.04 per share, receiving the same number of shares. That day he also completed open-market sales totaling 52,586 shares at $121.00 per share under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he holds 910,706 shares directly and 364 shares indirectly through a 401(k) plan.

Rhea-AI Summary

EchoStar chief legal officer Dean Manson exercised employee stock options for 10,000 shares of Class A Common Stock at $14.04 per share and sold 10,000 shares at $119.50 per share on June 4, 2026. The transactions were made under a pre-arranged Rule 10b5-1 trading plan. After these moves, he holds 5,058 shares directly and 1,143 shares indirectly.

Rhea-AI Summary

EchoStar director William David Wade exercised stock options to acquire additional shares. On May 18, 2026, he exercised a Non-Employee Director Stock Option covering 5,000 shares of EchoStar Class A Common Stock at $24.49 per share, converting the option into common stock and leaving zero options remaining from that grant.

Following the exercise, Wade directly holds 5,324 shares of Class A Common Stock. He also indirectly holds 443 shares through a trust, as noted in the footnote. The filing shows no open-market sale of shares; it reflects a derivative exercise that increases his direct share ownership.

Rhea-AI Summary

Telluray Holdings, LLC, a more than 10% owner of EchoStar CORP, reported updated holdings in EchoStar stock. It now directly holds 2,350,696 shares of Class A Common Stock and 60,517,502 shares of Class B Common Stock.

On May 13, 2026, an entity called the Ergen Two-Year May 2024 SATS GRAT transferred 2,925,750 Class B shares to Telluray Holdings in exchange for membership units in Telluray Holdings, a non-market restructuring transaction. The Class B shares may be converted into an equal number of Class A shares at any time for no additional consideration. Footnotes state that Mrs. Cantey M. Ergen has sole voting power over these shares, while she and Mr. Charles W. Ergen share dispositive power as managers of Telluray Holdings.

Rhea-AI Summary

EchoStar CORP’s Ergen Two-Year May 2025 SATS GRAT, a ten percent owner, reported a bona fide gift of 1,902,790 shares of Class B Common Stock on May 13, 2026. The distribution was made to Mr. Ergen as an annuity payment under the trust’s terms.

After this transfer, the 2025 May GRAT continues to hold 23,097,210 Class B shares. Each Class B share may be converted into an equal number of Class A shares at any time for no additional consideration. The 2025 May GRAT is scheduled to expire on May 13, 2027, and Mrs. Cantey M. Ergen serves as its trustee.

Rhea-AI Summary

EchoStar CORP insiders Charles W. Ergen and Cantey Ergen reported estate-planning moves involving Class B Common Stock linked to Class A shares. Several entries simply restate indirect and direct holdings in Class A and Class B stock.

The filing shows bona fide gifts of Class B shares and related transfers involving grantor retained annuity trusts (GRATs) and entities such as Telluray Holdings, LLC. One GRAT distributed 1,902,790 Class B shares to Mr. Ergen as an annuity payment and continued holding 23,097,210 Class B shares. Another GRAT distributed 381,135 Class B shares to Mr. Ergen and contributed 2,925,750 Class B shares to Telluray Holdings.

The Class B shares may be converted into an equal number of Class A shares for no additional consideration. After these non-market gifts and restructuring steps, Mr. Ergen continues to hold substantial direct and indirect positions in both classes of EchoStar stock.

Rhea-AI Summary

EchoStar CORP director and 10% owner Cantey Ergen received a grant of employee stock options covering 5,000 shares of Class A Common Stock. The options have an exercise price of $120.60 per share and expire on April 1, 2031.

The filing notes that all 5,000 underlying shares were 100% vested on the grant date, meaning they are immediately exercisable. This was a compensation-related award, not an open-market stock purchase or sale, and increased Ergen’s derivative holdings by the option amount reported.

Rhea-AI Summary

EchoStar CORP director Wade William David received a grant of stock options for 5,000 shares of Class A Common Stock. The options were awarded on April 1, 2026 with an exercise price of $120.60 per share and expire on April 1, 2031.

The filing states this is a non-employee director stock option, granted at no cost and classified as a grant or award acquisition rather than an open-market purchase. All 5,000 underlying shares became 100% vested on the grant date, and the director now holds options on 5,000 shares directly.

Rhea-AI Summary

EchoStar CORP director Tom A. Ortolf received a grant of stock options covering 5,000 shares of Class A Common Stock. The Non-Employee Director Stock Option was awarded at an exercise price of $120.60 per share and carries no upfront purchase price.

The option was 100% vested on the grant date and expires on April 1, 2031. Following this grant, Ortolf holds 5,000 stock options directly, giving him the right, but not the obligation, to buy 5,000 EchoStar Class A shares at $120.60 in the future.

Rhea-AI Summary

EchoStar CORP director Lisa W. Hershman received a grant of stock options covering 5,000 shares of Class A Common Stock. The non-employee director options have an exercise price of $120.60 per share and were fully vested on the grant date.

Following this grant, Hershman holds 5,000 stock options directly, with an expiration date of April 1, 2031. This is a compensation-related award, not an open-market purchase or sale of EchoStar common shares.

Rhea-AI Summary

EchoStar CORP director Dodge R. Stanton reported receiving a grant of stock options tied to the company’s Class A common stock. The award covers 5,000 Non-Employee Director Stock Options, each with an exercise price of $120.60 per share. According to the filing, the options were 100% vested on the grant date, so Stanton can choose to exercise them at any time before they expire. The options are scheduled to expire on April 1, 2031. Following this grant, Stanton holds derivative securities representing 5,000 underlying shares directly.

Rhea-AI Summary

EchoStar CORP director Stephen J. Bye received a grant of stock options tied to 5,000 shares of Class A Common Stock. The Non-Employee Director Stock Option was awarded at an exercise price of $120.60 per share and expires on April 1, 2031. The shares underlying the option were 100% vested on the grant date, and following this grant he holds 5,000 derivative securities directly.

Rhea-AI Summary

EchoStar CORP director George R. Brokaw received a grant of 5,000 stock options as compensation. These non-employee director options allow him to buy 5,000 shares of Class A Common Stock at an exercise price of $120.60 per share.

The options were 100% vested on the grant date, giving him immediate ability to exercise subject to their terms, and they expire on April 1, 2031. Following this grant, he holds 5,000 derivative securities directly, and there were no open-market purchases or sales reported in this filing.

Rhea-AI Summary

EchoStar CORP director Kathleen Q. Abernathy received a grant of stock options covering 5,000 shares of Class A Common Stock. The non-employee director stock option was awarded at an exercise price of $120.60 per share and carries no purchase price at grant.

The option expires on April 1, 2031 and all 5,000 underlying shares were 100% vested on the grant date, meaning they became exercisable immediately. Following this award, Abernathy holds derivative securities representing 5,000 shares directly as part of her director compensation, rather than through an open-market purchase.

Rhea-AI Summary

EchoStar CORP director and executive Hamid Akhavan exercised stock options and sold a portion of the resulting shares. On March 6, 2026, he exercised options for 20,417 Class A shares at $14.04 and 233,918 shares at $16.57, converting derivative awards into common stock.

On the same date, he conducted an open‑market sale of 71,005 Class A shares at an average price of $107.52, with trades ranging from $107.41 to $107.94 as disclosed in the footnotes. After these transactions, he directly holds 823,293 Class A shares and indirectly holds 327 additional shares through a 401(k) plan, indicating that most of the exercised shares were retained rather than sold.

Rhea-AI Summary

EchoStar CORP chief legal officer Dean Manson reported option exercises and share sales in Class A common stock. On March 5, 2026, he exercised employee stock options covering 7,631 shares and 14,000 shares at an exercise price of $14.04 per share, receiving the same number of Class A shares.

That day he sold 7,631 shares at a weighted average price of $114.51 (with individual prices from $114.31 to $114.80) and 11,400 shares at a weighted average price of $114.60 (prices from $114.33 to $114.80). After these transactions, he held 4,998 Class A shares directly and 1,106 shares indirectly through a 401(k).

Footnotes state that for one option grant, 40% of the underlying shares vested immediately and the remaining 60% vest 30% on each of April 1, 2025 and April 1, 2026. A separate option grant vests 25% each year on April 1, 2025, 2026, 2027 and 2028.

Rhea-AI Summary

EchoStar CORP officer John Swieringa reported option exercises and share sales in Class A common stock. On March 4, 2026, he exercised employee stock options for 35,088 shares, with 105,264 options remaining afterward, and received common shares at an exercise price of $16.57 per share.

That same day, he sold 15,000 shares at a weighted average price of $114.04 and 35,088 shares at a weighted average price of $113.39 in open-market transactions. After these trades, he directly owned 253,535 common shares and indirectly held 809 shares through a 401(k) account.

Rhea-AI Summary

EchoStar Corp19,038,378 shares of Class B common stock, convertible into an equal number of Class A shares for no additional consideration, is shown as resulting in zero derivative securities beneficially owned after the reported transaction.

Under the Ergen Two-Year December 2023 SATS GRAT, on December 22, 2025 the trust distributed 2,060,220 Class B shares to Mr. Ergen as an annuity payment and contributed the remaining 16,978,158 Class B shares to Telluray Holdings, LLC in exchange for membership units. The 2023 December GRAT then expired in accordance with its terms. The reporting person is identified as a director and 10% owner, and the filing is made for one reporting person.

Rhea-AI Summary

EchoStar Corp director and officer Hamid Akhavan reported exercising employee stock options for 285,832 shares of Class A common stock at an exercise price of $14.04 per share on December 11, 2025. On the same date, he reported multiple open-market sales of Class A common stock at weighted average sale prices described in the filing as ranging from $103.35 to $109.39, effected under a Rule 10b5-1 trading plan adopted on September 12, 2025.

After these transactions, Akhavan beneficially owns 376,805 Class A shares directly and 327 shares indirectly through a 401(k) plan. He also holds 122,500 employee stock options exercisable for Class A shares at $14.04 per share, expiring on April 1, 2034, with 60% of the underlying shares scheduled to vest 30% per year on April 1, 2025 and April 1, 2026.

Rhea-AI Summary

EchoStar Corp director Tom A. Ortolf reported insider transactions dated 12/11/2025 involving Class A common stock. He exercised a non-employee director stock option for 1,754 shares at $92.17 per share and then sold 1,754 shares at $104.06. After these moves, he owned 3,698 Class A shares directly.

He also had indirect ownership of 70 Class A shares held by his child and 35,644 Class A shares held through a partnership. The option covered 1,754 shares of Class A common stock and the shares underlying the option were 100% vested upon the date of the grant, leaving no derivative securities owned directly after the exercise.

Rhea-AI Summary

EchoStar CORP director George R. Brokaw reported a stock transaction involving the company’s Class A common stock. On 12/10/2025 he acquired 1,754 shares of Class A common stock at $92.17 per share in a transaction tied to a Non-Employee Director Stock Option with the same exercise price. After this transaction, he beneficially owned 4,508 shares of Class A common stock directly, and the reported stock option for 1,754 underlying shares showed zero derivative securities remaining. The filing notes that the shares underlying the option were 100% vested on the date of grant.

Rhea-AI Summary

EchoStar Corporation (SATS) reported an insider stock transaction by its President, Technology & COO. On 11/21/2025, the executive sold 22,000 shares of Class A Common Stock in an open market sale coded "S" at a price of $67.34 per share. After this transaction, the executive directly holds 283,509 Class A shares, which include shares acquired under the company’s Employee Stock Purchase Plan, and indirectly holds 809 shares through a 401(k) plan. The filing is a Form 4 submitted for one reporting person and reflects a routine update to the insider’s ownership position.

Rhea-AI Summary

EchoStar Corporation (SATS) director share purchase reported. A company director filed a Form 4 showing an open-market purchase of 1,000 shares of EchoStar Class A common stock on 11/18/2025 at a price of $68.07 per share, coded as a purchase transaction ("P"). Following this trade, the director now beneficially owns 2,754 shares of EchoStar Class A common stock held directly. No derivative security transactions were reported in this filing.

Rhea-AI Summary

Paul W. Orban, EVP and CFO of EchoStar Corp (SATS), reported a grant of 50,000 restricted stock units (RSUs) effective 10/01/2025. Each RSU converts to one share of Class A common stock upon vesting; the RSUs vest at 20% per year beginning 10/01/2026, implying a five‑year vesting schedule. The filing shows total beneficial ownership of 50,470 Class A shares after the award, which combines the new 50,000 RSUs and 470 existing shares held directly. The report was signed by an attorney‑in‑fact on behalf of Mr. Orban on 10/03/2025.

Rhea-AI Summary

John W. Swieringa, President, Technology & COO of EchoStar Corp (SATS), reported multiple equity transactions dated 10/01/2025. He had 50,000 restricted stock units vest (recorded as acquired at $0) and 60,000 employee stock options were acquired with an exercise price of $79.50 and an expiration of 10/01/2035. The filing shows 22,125 shares were withheld and disposed to cover tax obligations at a price of $79.50. After these transactions, Swieringa beneficially owned 305,509 Class A shares (direct), which includes shares from RSU vesting and the Companys Employee Stock Purchase Plan; an additional 809 shares are held indirectly via a 401(k).

Rhea-AI Summary

EchoStar (SATS) reported a Form 4 for Chief Legal Officer Dean A. Manson showing a grant of 15,000 employee stock options at an exercise price of $79.5 on October 1, 2025.

The options vest in three equal annual installments beginning on October 1, 2026 and expire on October 1, 2035. Following the grant, 15,000 derivative securities were beneficially owned, reported as Direct (D) ownership.

Rhea-AI Summary

EchoStar Corp director and President & CEO Hamid Akhavan reported option exercise and share sales on 09/12/2025. He exercised 233,918 employee stock options at an exercise price of $16.57, creating 233,918 Class A shares. Following the exercise, Akhavan sold those shares in two transactions: 170,824 shares at a weighted average price of $74.93 and 63,094 shares at a weighted average price of $76.50, together equal to the 233,918 shares acquired. After these transactions he beneficially owned 376,805 Class A shares directly and 327 shares indirectly via a 401(k). The option vests in three equal annual installments beginning December 31, 2024, and the exercised options have an expiration date of December 31, 2033.

Rhea-AI Summary

Paul Gaske, identified as COO, HUGHES and a reporting person for EchoStar CORP (SATS), reported multiple transactions dated 09/12/2025. The Form 4 shows several dispositions of Class A common stock (codes S) at prices ranging from $75.63 to $78.32 and acquisitions recorded with code M at $14.04. Reported non-derivative activity includes sales of 750, 1,444, 2,964, 5,075 shares and acquisitions of 2,964 and 5,075 shares (as shown). Table II reports two employee stock option grants at an exercise price of $14.04 dated 09/12/2025: one for 2,964 options and one for 5,075, each exercisable on specified dates with expiration 04/01/2034. The filing includes vesting schedules: 40% of one option grant vested immediately with remaining vesting on April 1, 2025 and April 1, 2026; the other grant vests 25% per year from April 1, 2025 through April 1, 2028. The form is signed by Paul Gaske via attorney-in-fact on 09/16/2025.